- Staat
- NC
- Alter
- 58,0
- Geschlecht
- F
- Eingang
- 14.07.2021
- Impfdatum
- 13.07.2021
- Beginn
- 13.07.2021
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Injected limb mobility decreased
Limb discomfort
Myalgia
Symptomtext
Patient self reported feeling the needle entering her muscle and feeling the Shingrix vaccine being injected into her muscle at the time of vaccination. She reported intense, sore muscle pain in vaccinated arm 2 to 3 hours later, including a feeling of "heavy arm" and couldn't raise her arm above her shoulder. Patient self administered Tylenol and heat compresses and stated that the heat seemed to make it worse but the Tylenol seemed to help. She took her usual prescription of Meloxicam 7.5mg 2 tablets at bedtime and stated the following morning 7/14/21 that her arm felt much better and she had better range of motion than yesterday but still not normal. There is no redness or swelling noted by the patient. Discussed side effect of Shingrix with patient and advised to use cold compresses and seek medical attention if the condition becomes worse or if it remains after 2-3 days from vaccination date.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injected limb mobility decreased
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- Mitral valve prolapse, seasonal allergies and arthritis
- Vorgeschichte
- Arthritis, mitral valve prolapse, seasonal allergies
- Andere Medikamente
- Meloxicam 7.5 mg every evening at bedtime.
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 68,0
- Geschlecht
- M
- Eingang
- 06.05.2021
- Impfdatum
- 30.04.2021
- Beginn
- 02.05.2021
- Tage bis Beginn
- 2,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Computerised tomogram
Dyspnoea
Influenza like illness
Neck pain
Pain
Painful respiration
Sleep disorder
Symptomtext
PATIENT REPORTED FEELING FLU LIKE SYMPOTOMS DAY AFTER INJECTION WHICH WAS EXPECTED. HOWEVER STARTING SUNDAY EVENING HE BEGAN TO HAVE PAIN IN HIS LEFT AREA OF HIS NECK. THAT PAIN THEN BEGAN TO RADIATE DOWN TO HIS LEFT SIDE. THE PAIN BEGAN TO GET MORE INTENSE TO WHERE MONDAY EVENING HE WAS HAVING DIFFICULTY TAKING A DEEP BREATH. MONDAY NIGHT HE WAS UNABLE TO SLEEP DUE TO PAIN AND SHORTNESS OF BREATH. TUESDAY MORNING HE CONTACTED DOCTOR AND THEY SENT HIM FOR CT SCAN. THE SCAN SHOWED A PULMONARY EMBOLISM IN HIS RIGHT LUNG WITH EFFUSION SHOWING IN LEFT LUNG. THE ONLY THING DIFFERENT PATINET DID DURING THIS TIME IS GET THE SHINGRIX VACCINE. DOCTOR THEN PUT PATIENT ON ELIQUIS FOR TREATMENT.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dyspnoea
- Hospital-Tage
- -
- Labordaten
- CT
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 67,0
- Geschlecht
- F
- Eingang
- 19.02.2021
- Impfdatum
- 12.02.2021
- Beginn
- 19.02.2021
- Tage bis Beginn
- 7,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: ja
Dyspnoea
Nausea
Pain
Symptomtext
Approximately 10 minutes after receiving vaccine patient began filling nauseous. Later that evening patient went to hospital because she thought she was having a heart attack. Entire left side of body was in pain and she was having a hard time breathing.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dyspnoea
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- Shingrix dose 1 on 10/20/2020. age 66. Felt severe flu-like symptoms and was in bed for 4 days.
- Staat
- MI
- Alter
- 56,0
- Geschlecht
- F
- Eingang
- 18.01.2021
- Impfdatum
- 15.01.2021
- Beginn
- 15.01.2021
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Dyspnoea
Injection site erythema
Pain in extremity
Pyrexia
Symptomtext
Pt called pharmacy 1/18/21 to report sore arm the day of injection and new developing redness below injection site. Pt stated arm pain was so significant she left work to go home. Pt denied any other symptoms -fever, shortness of breath, swelling. RPh advised patient to use cool compresses and tylenol for pain and to keep arm moving.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dyspnoea
- Hospital-Tage
- -
- Labordaten
- NA
- Aktuelle Erkrankungen
- NA
- Vorgeschichte
- hypertension, diabetes
- Andere Medikamente
- Arimidex 1 mg QD, Januvia 100 mg QD, Losartan 100 QD, Glyburide 5 mg 2 c breakfast + 1 c dinner.
- Allergien
- iodine
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 67,0
- Geschlecht
- F
- Eingang
- 15.01.2021
- Impfdatum
- 12.01.2021
- Beginn
- 12.01.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Fatigue
Headache
Injection site pain
Palpitations
Pruritus
Rash
Urticaria
Symptomtext
Patient reports pain at the injection site lasting from 01/12/21 at time of administration until the morning of 01/14/21. Patient reports heart palpitations during the evening of 01/13/21 and hives/rash that developed on 01/13/21 starting on the upper back and has now spread to abdomen and both armpits. Patient took Benadryl on 01/14/21 around 8pm and itching/sensitivity is lessened. Patient reports fatigue on 01/13/21. Patient reports headache on 01/12/21 which subsided with the use of acetaminophen. Patient states headache returned on 01/13/21 to a lesser degree and resolved on its own. Patient denies continued heart palpitations.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Palpitations
- Hospital-Tage
- -
- Labordaten
- NA
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- HYPOTHYROIDISM
- Andere Medikamente
- Levothyroxine 75 MCG
- Allergien
- SULFONAMIDE ANTIBIOTICS
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- 72,0
- Geschlecht
- F
- Eingang
- 18.05.2021
- Impfdatum
- 03.05.2021
- Beginn
- 03.05.2021
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Headache
Immediate post-injection reaction
Inappropriate schedule of product administration
Injection site erythema
Injection site inflammation
Skin warm
Symptomtext
a round (approximately 2.5 inches in diameter) area of inflammation / at the injection site; redness at the injection site; skin was warm to touch; also experienced a headache; first dose of Shingrix April 5, 2021 / on May 3, 2021 / received the second vaccine; This case was reported by a consumer via call center representative and described the occurrence of injection site inflammation in a 72-year-old female patient who received Herpes zoster (Shingrix) (batch number F5XN2, expiry date 8th October 2022) for prophylaxis. Concomitant products included Herpes zoster (Shingrix). On 3rd May 2021, the patient received the 2nd dose of Shingrix (intramuscular). On 3rd May 2021, immediately after receiving Shingrix and an unknown time after receiving Shingrix, the patient experienced injection site inflammation, injection site erythema, skin warm, headache and drug dose administration interval too short. On 7th May 2021, the outcome of the injection site inflammation was recovering/resolving. On an unknown date, the outcome of the injection site erythema and skin warm were recovering/resolving and the outcome of the headache was not recovered/not resolved and the outcome of the drug dose administration interval too short was unknown. It was unknown if the reporter considered the injection site inflammation, injection site erythema, skin warm and headache to be related to Shingrix. Additional information was provided as follows: On 5th April 2021, the patient received 1st dose of Shingrix. The patient was instructed to return to receive 2nd dose of shingrix and the patient received 2nd dose of Shingrix, less than the recommended interval, which led to shortening of vaccination schedule. Immediately after receiving 2nd dose, the patient noticed a round (approximately 2.5 inches in diameter) area of inflammation and redness at the injection site. The skin was warm to touch. Those symptoms had improved. On the same day, she also experienced a headache and continued till the reporting date. The reporter consented to follow up via email as well as with her HCP (health care professional).
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Headache
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 50,0
- Geschlecht
- F
- Eingang
- 26.04.2021
- Impfdatum
- 14.04.2021
- Beginn
- 15.04.2021
- Tage bis Beginn
- 1,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Chills
Headache
Injection site erythema
Injection site warmth
Pain
Symptomtext
2 inch redness and warmth on left arm where vaccine was administered headache, chills, body aches Tylenol 500mg 2 tablets as needed
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Chills
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- wrist pain, hip pain
- Vorgeschichte
- none
- Andere Medikamente
- none
- Allergien
- none
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 81,0
- Geschlecht
- F
- Eingang
- 27.03.2021
- Impfdatum
- 23.03.2021
- Beginn
- 24.03.2021
- Tage bis Beginn
- 1,0
- Dosis
- 1
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Abdominal pain upper
Arthralgia
Chills
Fatigue
Headache
Injection site inflammation
Injection site pain
Nausea
Symptomtext
Nausea, stomach pain, joint pain, chills, headache, fatigue, sore and inflamed injection site.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Abdominal pain upper
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- Lupus, EPI
- Andere Medikamente
- Prednisone, Hydroxychloroquine, Levothyroxine, Triamterene, Zanaflex, Zenpep, fish oil, vitamin D3, calcium, cranberry, biotin, PreserVision, melatonin,
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- 52,0
- Geschlecht
- M
- Eingang
- 20.03.2021
- Impfdatum
- 19.03.2021
- Beginn
- 19.03.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Fatigue
Headache
Pain in extremity
Pyrexia
Symptomtext
Immediate fatigue, moderate arm soreness, then developed 100.0 fever that persists into Day 2, and unresponsive to 2X extra strength tylenol. Severe headache.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Fatigue
- Hospital-Tage
- -
- Labordaten
- None.
- Aktuelle Erkrankungen
- COVID-19 vaccination January 25 and February 15 (Pfizer)--never had COVID-19 no illness.
- Vorgeschichte
- Migraines, hypertension, coronary artery disease, coronary artery stent placement, asthma, sciatic neuropathy, barrett esophagus/esophageal reflux, hyperlipidemia, Cranial Plate (at 7 years old), former smoker (stopped 2005), carpal tunnel syndrome
- Andere Medikamente
- Atorvastatin 80mg, Lisinopril-HCTZ 20-25mg, Montelukast Sod 10mg, Nifedipine ER 90mg, Aimovig 140mg/ml (1xmonthly), Diazepam 2mg, Lisinopril 20mg (PM), low dose aspirin, CoQ10, Multivitamin
- Allergien
- NKA, NKFA, NKDA
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 64,0
- Geschlecht
- F
- Eingang
- 25.02.2021
- Impfdatum
- 15.01.2021
- Beginn
- 15.01.2021
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Anal incontinence
Breast pain
Defaecation urgency
Nipple pain
Symptomtext
Patient stated at time of administration she felt the injection go into her breast, nipple, and areola. She stated she was shopping and felt she couldn't hold her bowels and accidentally defecated in the aisle of the store. She says she has lasting nausea and sudden urges to defecate.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Breast pain
- Hospital-Tage
- -
- Labordaten
- none to my knowledge
- Aktuelle Erkrankungen
- unknown
- Vorgeschichte
- unknown
- Andere Medikamente
- acyclovir 400mg
- Allergien
- penicillins
- Vorherige Impfungen
- -
- Staat
- PA
- Alter
- 84,0
- Geschlecht
- F
- Eingang
- 09.02.2021
- Impfdatum
- 08.02.2021
- Beginn
- 09.02.2021
- Tage bis Beginn
- 1,0
- Dosis
- 2
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Pyrexia
Symptomtext
Pt had complained of fever
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pyrexia
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- hypercholesterolemia, depression
- Andere Medikamente
- Pt said she had a fever
- Allergien
- none
- Vorherige Impfungen
- -
- Staat
- AZ
- Alter
- 70,0
- Geschlecht
- F
- Eingang
- 22.01.2021
- Impfdatum
- 20.01.2021
- Beginn
- 22.01.2021
- Tage bis Beginn
- 2,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Erythema
Injection site erythema
Injection site swelling
Injection site warmth
Musculoskeletal discomfort
Peripheral swelling
Pruritus
Symptomtext
redness, swelling at injection site, heat, itching on neck, arm and redness swelling on the inside of the elbow joint
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site erythema
- Hospital-Tage
- -
- Labordaten
- none at this time
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- none
- Andere Medikamente
- align pro biotic laxatives blood pressure anxiety
- Allergien
- no known allergies
- Vorherige Impfungen
- -
- Staat
- KY
- Alter
- 62,0
- Geschlecht
- F
- Eingang
- 19.01.2021
- Impfdatum
- 13.01.2021
- Beginn
- 13.01.2021
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Injection site erythema
Injection site nodule
Injection site pain
Injection site swelling
Symptomtext
Marble-sized knot at injection site. Redness around injection site and swelling/pain around injection site.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site erythema
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WA
- Alter
- 70,0
- Geschlecht
- F
- Eingang
- 16.01.2021
- Impfdatum
- 13.01.2021
- Beginn
- 15.01.2021
- Tage bis Beginn
- 2,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Injection site rash
Pain in extremity
Symptomtext
patient noticed round 'rash' in left armpit on Friday 1/15/2021, it's just an outline of a circle patient's arm was sore locally for a couple days but nothing else presented, including itching, dryness, muscle aches, fever, or any other body symptoms.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site rash
- Hospital-Tage
- -
- Labordaten
- none she stated she was calling her physician if it progressed by Monday I also asked to keep us informed, and she consented
- Aktuelle Erkrankungen
- none known
- Vorgeschichte
- none known
- Andere Medikamente
- not known
- Allergien
- no known allergies
- Vorherige Impfungen
- -
- Staat
- OR
- Alter
- 50,0
- Geschlecht
- F
- Eingang
- 09.01.2021
- Impfdatum
- 08.01.2021
- Beginn
- 08.01.2021
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Rash
Urticaria
Symptomtext
Hives and rash over torso and spreading
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Rash
- Hospital-Tage
- -
- Labordaten
- None reported
- Aktuelle Erkrankungen
- none reported
- Vorgeschichte
- none reported
- Andere Medikamente
- Tramadol ER 100mg; Cyclobenzaprine 10mg; Estradiol 0.5mg; Trazodone 100mg; Buspirone 15mg; Gabapentin 600mg; Ibuprofen 800mg; Alendronate 70mg; Acyclovir 400mg
- Allergien
- penicillin, metronidazole, soy, sulfa
- Vorherige Impfungen
- -
- Staat
- KY
- Alter
- 75,0
- Geschlecht
- M
- Eingang
- 24.08.2021
- Impfdatum
- 23.08.2021
- Beginn
- 23.08.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Blood pressure increased
Epistaxis
Symptomtext
Blood pressure elevated outside of normal (~130/80) to ~147/90. Patient also had a nose bleed that was difficult to stop.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Blood pressure increased
- Hospital-Tage
- -
- Labordaten
- N/A
- Aktuelle Erkrankungen
- None provided
- Vorgeschichte
- None provided
- Andere Medikamente
- Unsure
- Allergien
- None provided
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 89,0
- Geschlecht
- F
- Eingang
- 08.06.2021
- Impfdatum
- 29.05.2021
- Beginn
- 29.05.2021
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Inappropriate schedule of product administration
Symptomtext
administration of the second dose after 2 weeks of receiving the first dose / first dose / on 5/13/2021 /second dose on 5/29/2021; This case was reported by a pharmacist via call center representative and described the occurrence of drug dose administration interval too short in a 89-year-old female patient who received Herpes zoster (Shingrix) (batch number F5XN2, expiry date 8th October 2022) for prophylaxis. Concomitant products included Herpes zoster (Shingrix). On 29th May 2021, the patient received the 2nd dose of Shingrix. On 29th May 2021, unknown after receiving Shingrix and 16 days after receiving Shingrix, the patient experienced drug dose administration interval too short. On an unknown date, the outcome of the drug dose administration interval too short was unknown. Additional details were reported as follows: The patient received 2nd dose less than 2 month apart from the 1st dose, which led to shortening of vaccination schedule. No further event was reported. The health care professional consented to follow-up
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Inappropriate schedule of product administration
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 89,0
- Geschlecht
- F
- Eingang
- 02.06.2021
- Impfdatum
- 29.05.2021
- Beginn
- 29.05.2021
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Unevaluable event
Symptomtext
Patient has not reported any signs or symptoms of side effects since vaccine was given.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Unevaluable event
- Hospital-Tage
- -
- Labordaten
- N/A
- Aktuelle Erkrankungen
- Infection
- Vorgeschichte
- Mental disorder, mood disorder, thyroid disorder, high blood pressure, high cholesterol
- Andere Medikamente
- Primidone, escitalopram, simvastatin, sertraline, rivastigmine, oxybutynin, lisinopril-hctz, levothyroxine, mirtazapine, memantine
- Allergien
- No known allergies
- Vorherige Impfungen
- -
- Staat
- IL
- Alter
- 55,0
- Geschlecht
- F
- Eingang
- 05.05.2021
- Impfdatum
- 29.04.2021
- Beginn
- 29.04.2021
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Inappropriate schedule of product administration
Symptomtext
Second dose / on April 39th 2021 / first dose was / on March 12th 2021; This case was reported by a nurse via call center representative and described the occurrence of drug dose administration interval too short in a 55-year-old female patient who received Herpes zoster (Shingrix) (batch number F5XN2, expiry date 8th October 2022) for prophylaxis. Concomitant products included Herpes zoster (Shingrix). On 29th April 2021, the patient received the 2nd dose of Shingrix. On 29th April 2021, unknown after receiving Shingrix and an unknown time after receiving Shingrix, the patient experienced drug dose administration interval too short. On an unknown date, the outcome of the drug dose administration interval too short was unknown. Additional information was provided as follows: The patient received 1st dose of Shingrix on 12 March 2021. The nurse reported that the patient received 2nd dose of Shingrix, less than recommended interval, which led to shortening of vaccination schedule. The reporter did not consent to follow up.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Inappropriate schedule of product administration
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- Shingrix
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- KS
- Alter
- 51,0
- Geschlecht
- F
- Eingang
- 06.04.2021
- Impfdatum
- 05.04.2021
- Beginn
- 05.04.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Inappropriate schedule of product administration
No adverse event
Symptomtext
Wasn't aware that I was in 14 days of patient's second Covid-19 vaccine. That was given on 3/30/21. Pt was unconcerned, followed up with patient today and she feels fine.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Inappropriate schedule of product administration
- Hospital-Tage
- -
- Labordaten
- none.
- Aktuelle Erkrankungen
- no known
- Vorgeschichte
- depression
- Andere Medikamente
- sertraline
- Allergien
- no known
- Vorherige Impfungen
- -
- Staat
- KY
- Alter
- 51,0
- Geschlecht
- M
- Eingang
- 21.02.2021
- Impfdatum
- 18.02.2021
- Beginn
- 18.02.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Lymphadenopathy
Symptomtext
Patient reported a swollen lymph node after receiving the Shingrix vaccine
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Lymphadenopathy
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- none
- Andere Medikamente
- none
- Allergien
- none
- Vorherige Impfungen
- -